Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1945 1
1946 2
1949 3
1960 1
1962 2
1965 3
1966 3
1967 4
1968 5
1969 1
1970 5
1971 7
1972 3
1973 3
1974 1
1975 2
1976 4
1977 1
1978 2
1979 6
1981 1
1982 2
1983 2
1985 2
1986 8
1987 2
1988 5
1989 8
1990 2
1991 2
1992 4
1993 3
1994 9
1995 6
1996 6
1997 5
1998 5
1999 8
2000 7
2001 4
2002 8
2003 7
2004 7
2005 10
2006 9
2007 20
2008 17
2009 16
2010 16
2011 19
2012 13
2013 22
2014 29
2015 35
2016 39
2017 54
2018 56
2019 66
2020 57
2021 75
2022 93
2023 89
2024 157
2025 60

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

999 results

Results by year

Filters applied: . Clear all
Page 1
Mechanisms of motor symptom improvement by long-term Tai Chi training in Parkinson's disease patients.
Li G, Huang P, Cui SS, Tan YY, He YC, Shen X, Jiang QY, Huang P, He GY, Li BY, Li YX, Xu J, Wang Z, Chen SD. Li G, et al. Transl Neurodegener. 2022 Feb 7;11(1):6. doi: 10.1186/s40035-022-00280-7. Transl Neurodegener. 2022. PMID: 35125106 Free PMC article. Clinical Trial.
BACKGROUND: Tai Chi has been shown to improve motor symptoms in Parkinson's disease (PD), but its long-term effects and the related mechanisms remain to be elucidated. ...
BACKGROUND: Tai Chi has been shown to improve motor symptoms in Parkinson's disease (PD), but its long-term effects and …
The mutation spectrum of Parkinson-disease-related genes in early-onset Parkinson's disease in ethnic Chinese.
Chen YP, Yu SH, Zhang GH, Hou YB, Gu XJ, Ou RW, Shen Y, Song W, Chen XP, Zhao B, Cao B, Zhang LY, Sun MM, Liu FF, Wei QQ, Liu KC, Lin JY, Yang TM, Yang J, Wu Y, Jiang Z, Liu J, Cheng YF, Xiao Y, Su WM, Feng F, Cai YY, Li SR, Hu T, Yuan XQ, Zhou QQ, Shao N, Ma S, Shang HF. Chen YP, et al. Eur J Neurol. 2022 Nov;29(11):3218-3228. doi: 10.1111/ene.15509. Epub 2022 Aug 4. Eur J Neurol. 2022. PMID: 35861376
BACKGROUND AND PURPOSE: Recent genetic progress has shown many causative/risk genes linked to Parkinson's disease (PD), mainly in patients of European ancestry. The study aimed to investigate the PD-related genes and determine the mutational spectrum of early …
BACKGROUND AND PURPOSE: Recent genetic progress has shown many causative/risk genes linked to Parkinson's disease (PD), …
Neuroimaging of Parkinson's disease by quantitative susceptibility mapping.
Guan X, Lancione M, Ayton S, Dusek P, Langkammer C, Zhang M. Guan X, et al. Neuroimage. 2024 Apr 1;289:120547. doi: 10.1016/j.neuroimage.2024.120547. Epub 2024 Feb 18. Neuroimage. 2024. PMID: 38373677 Free article. Review.
Parkinson's disease (PD) is a common neurodegenerative disease, and apart from a few rare genetic causes, its pathogenesis remains largely unclear. ...The initiation of multi-site research is warranted for developing robust, interpretable, and disea …
Parkinson's disease (PD) is a common neurodegenerative disease, and apart from a few rare genetic causes, its pa …
Prasinezumab slows motor progression in rapidly progressing early-stage Parkinson's disease.
Pagano G, Taylor KI, Anzures Cabrera J, Simuni T, Marek K, Postuma RB, Pavese N, Stocchi F, Brockmann K, Svoboda H, Trundell D, Monnet A, Doody R, Fontoura P, Kerchner GA, Brundin P, Nikolcheva T, Bonni A; PASADENA Investigators; Prasinezumab Study Group. Pagano G, et al. Nat Med. 2024 Apr;30(4):1096-1103. doi: 10.1038/s41591-024-02886-y. Epub 2024 Apr 15. Nat Med. 2024. PMID: 38622249 Free PMC article.
Prasinezumab, a monoclonal antibody that binds aggregated alpha-synuclein, is being investigated as a potential disease-modifying therapy in early-stage Parkinson's disease. Although in the PASADENA phase 2 study, the primary endpoint (Movement Disorde …
Prasinezumab, a monoclonal antibody that binds aggregated alpha-synuclein, is being investigated as a potential disease-modifying the …
Regulation of Neurotransmitters by the Gut Microbiota and Effects on Cognition in Neurological Disorders.
Chen Y, Xu J, Chen Y. Chen Y, et al. Nutrients. 2021 Jun 19;13(6):2099. doi: 10.3390/nu13062099. Nutrients. 2021. PMID: 34205336 Free PMC article. Review.
We also discuss how microbiome dysbiosis affects cognitive function, especially in neurodegenerative diseases such as Alzheimer's disease and Parkinson's disease....
We also discuss how microbiome dysbiosis affects cognitive function, especially in neurodegenerative diseases such as Alzheimer's …
Shared Genetics and Comorbid Genes of Amyotrophic Lateral Sclerosis and Parkinson's Disease.
Tian Y, Ma G, Li H, Zeng Y, Zhou S, Wang X, Shan S, Xu Y, Xiong J, Cheng G. Tian Y, et al. Mov Disord. 2023 Oct;38(10):1813-1821. doi: 10.1002/mds.29572. Epub 2023 Aug 3. Mov Disord. 2023. PMID: 37534731
BACKGROUND: Comorbidity exists between amyotrophic lateral sclerosis (ALS) and Parkinson's disease (PD), but the role of genetic factors is unclear. OBJECTIVE: We aim to investigate genetic correlation, causal relationship, and comorbid genes between ALS and …
BACKGROUND: Comorbidity exists between amyotrophic lateral sclerosis (ALS) and Parkinson's disease (PD), but the role o …
Microglial CR3 promotes neuron ferroptosis via NOX2-mediated iron deposition in rotenone-induced experimental models of Parkinson's disease.
Wang Q, Liu J, Zhang Y, Li Z, Zhao Z, Jiang W, Zhao J, Hou L, Wang Q. Wang Q, et al. Redox Biol. 2024 Nov;77:103369. doi: 10.1016/j.redox.2024.103369. Epub 2024 Sep 24. Redox Biol. 2024. PMID: 39357423 Free PMC article.
The activation of complement receptor 3 (CR3) in microglia contributes to neurodegeneration in neurological disorders, including Parkinson's disease (PD). However, it remains unclear for mechanistic knowledge on how CR3 mediates neuronal damage. ...
The activation of complement receptor 3 (CR3) in microglia contributes to neurodegeneration in neurological disorders, including Parkinso …
Oral, Nasal, and Gut Microbiota in Parkinson's Disease.
Li Z, Lu G, Luo E, Wu B, Li Z, Guo J, Xia Z, Zheng C, Su Q, Zeng Y, Chan WY, Su X, Qiu X, Zheng X, Cai Q, Xu Y, Chen Y, Fan Y, Chen W, Yu Z, Chen X, Zheng C, Wang M, Poon WS, Luo X. Li Z, et al. Neuroscience. 2022 Jan 1;480:65-78. doi: 10.1016/j.neuroscience.2021.10.011. Epub 2021 Oct 22. Neuroscience. 2022. PMID: 34695538
Parkinson's disease (PD) is the second most frequently diagnosed neurodegenerative disease. ...Overall, our results indicate that oral and gut dysbiosis may affect PD progression and provide a basis for understanding the pathogenesis of PD and identify …
Parkinson's disease (PD) is the second most frequently diagnosed neurodegenerative disease. ...Overall, our resu …
Joint analysis of proteome, transcriptome, and multi-trait analysis to identify novel Parkinson's disease risk genes.
Shi JJ, Mao CY, Guo YZ, Fan Y, Hao XY, Li SJ, Tian J, Hu ZW, Li MJ, Li JD, Ma DR, Guo MN, Zuo CY, Liang YY, Xu YM, Yang J, Shi CH. Shi JJ, et al. Aging (Albany NY). 2024 Jan 17;16(2):1555-1580. doi: 10.18632/aging.205444. Epub 2024 Jan 17. Aging (Albany NY). 2024. PMID: 38240717 Free PMC article.
Genome-wide association studies (GWAS) have identified multiple risk variants for Parkinson's disease (PD). Nevertheless, how the risk variants confer the risk of PD remains largely unknown. ...In this large-scale study, we identified 16 genes whose genetical …
Genome-wide association studies (GWAS) have identified multiple risk variants for Parkinson's disease (PD). Nevertheles …
Risk of Parkinson's disease in a gout Mediterranean population: A case-control study.
Pou MA, Orfila F, Pagonabarraga J, Ferrer-Moret S, Corominas H, Diaz-Torne C. Pou MA, et al. Joint Bone Spine. 2022 Nov;89(6):105402. doi: 10.1016/j.jbspin.2022.105402. Epub 2022 Apr 30. Joint Bone Spine. 2022. PMID: 35504516
INTRODUCTION: High levels of serum urate has been associated to a neuroprotective effect in Parkinson's disease (PD) as an antioxidant agent. However, the relation between gout and PD remains contradictory. ...
INTRODUCTION: High levels of serum urate has been associated to a neuroprotective effect in Parkinson's disease (PD) as …
999 results